Stocktoria
UNITED THERAPEUTICS Corp UTHR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1999-06-17
UNITED THERAPEUTICS Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 87.9% | 89.2% | 88.9% | 92.2% | 92.7% |
| Operating margin | 46.9% | 47.9% | 50.9% | 50.6% | 33.0% |
| Net margin | 41.9% | 41.5% | 42.3% | 37.6% | 28.2% |
| FCF margin | 32.7% | 37.6% | 32.1% | 34.3% | 28.3% |
| Return on assets | 16.9% | 16.2% | 13.7% | 12.0% | 9.2% |
| Return on equity | 18.8% | 18.5% | 16.5% | 15.2% | 12.0% |
| Current ratio | 6.60 | 5.25 | 4.41 | 9.85 | 7.61 |
| Revenue growth | 10.6% | 23.6% | 20.2% | 14.9% | 13.6% |
Source: SEC EDGAR filings · CIK 0001082554 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.